Effects of mefenamic acid on menstrual hemostasis in essential menorrhagia

M. A. Van Eijkeren, G. C. M. L. Christiaens, G C Christiaens, Hans J. Geuze, H J Geuze, Ary A. Haspels, A A Haspels, Jan J. Sixma, J J Sixma
American journal of obstetrics and gynecology · 1992 · vol. 166(5) , pp. 1419–1428 · doi:10.1016/0002-9378(92)91614-g · PMID:1595797 · W1981558025
Non-randomised trial OA: closed CC0 ⤵ 15 in-corpus citations
View on OpenAlex View on PubMed View at publisher
⚙ AI-generated summary by gemini-2.5-flash-lite, 2026-06-12 ⓘ

Mefenamic acid was evaluated for its ability to reduce blood loss in women experiencing heavy menstrual bleeding due to essential menorrhagia.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

Prostaglandin synthesis inhibitors decrease menstrual blood loss by 30% to 50% in patients with essential menorrhagia. To obtain insight into their mechanism of action, we measured menstrual blood loss in menorrhagic women, who were receiving mefenamic acid (500 mg, three times daily) (n = 6) or placebo (n = 5) in a double-blind way. In addition we studied the morphology of early menstrual hemostasis. The subjects' uteri were extirpated in the first 24 hours of menstruation, and light and electron microscopy were used to perform morphologic and morphometric studies. In the group treated with mefenamic acid mean menstrual blood loss was decreased by 40%. In uteri of the women treated with mefenamic acid hemostatic plugs were further transformed, and fewer vessels without a plug were observed than in uteri of the group receiving placebo. These data suggest that mefenamic acid may act through an improvement of platelet aggregation and degranulation and through increased vasoconstriction.

My notes (saved in your browser only)

MeSH descriptors

Hemostasis Mefenamic Acid Menorrhagia Adult Arterioles Arterioles Endometrium Endometrium Endometrium Female Humans Mefenamic Acid Menorrhagia Menorrhagia Menorrhagia Microscopy, Electron Platelet Aggregation Uterus Uterus Vasoconstriction

Citation neighborhood (2-hop)

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. Outer rings show 2-hop neighbours — papers reached through the immediate citers/citees. [ collapse to 1-hop ]

References (23)

Cited by (13)

Source provenance

openalex
last seen: 2026-06-10T17:14:06.276822+00:00
pubmed
last seen: 2026-10-08T21:03:11.681822+00:00
License: CC0 · commercial use OK